Introduction
Vitamin D is the major regulator of calcium metabolism and hence is an important determinant of bone health Van Leeuwen et al, 2001) . Prolonged and severe vitamin D deficiency leads to rickets in children and osteomalacia in adults (Compston, 1998) , whereas less severe vitamin D deficiency causes secondary hyperparathyroidism, increases bone turnover and bone loss mainly from cortical sites such as the femoral neck (Parfitt et al, 1982; Lips et al, 1982 Lips et al, , 1987 Ooms et al, 1995; . There is also growing evidence for the contribution of vitamin D insufficiency (ie, serum 25-hydroxyvitamin D (25 (OH) D) levels below 50 nmol/l) to the development of various chronic diseases (eg, some inflammatory and autoimmune diseases, some forms of cancer, hypertension, cardiovascular diseases and diabetes mellitus), which are frequent in Western societies (for review, see Zittermann, 2003; Holick, 2004) .
In humans, vitamin D is obtained primarily through cutaneous biosynthesis in the presence of UVB sunlight and but also from the diet (Parfitt et al, 1982) . Consequently, season is a major determinant of vitamin D status (Stamp & Round, 1974) . Vitamin D status is highest in northern European populations around late-summer (August/september) and lowest around late-winter/early-spring (February/ March) (McKenna, 1992; Lips et al, 2001) . In northern Europe (latitude 40-601N), including Ireland (latitude 51-551N), sunlight is too weak during the winter months (ie, October/November to February/March) to stimulate cutaneous vitamin D synthesis (Webb et al, 1988; Food and Agriculture Organization/World Health Organization, 1998) . This creates an increased reliance on dietary sources during these winter months to help maintain adequate vitamin D status. However, the usual dietary vitamin D intake in Europe is not sufficient to maintain adequate vitamin D status especially during wintertime (Van Der Wielen et al, 1995 ; see review by Ovesen et al, 2003) .
There are very few natural sources of vitamin D that are commonly consumed in Ireland. A recent analysis of the North/South Ireland Food Consumption Survey for vitamin intakes (Hill et al, 2004) estimated that the mean daily intake of vitamin D was 4.2 mg in adult men and women (aged 18-64 y) from all sources, including nutritional supplements. These intake data show that a considerable proportion of Irish adults have very low dietary intakes of vitamin D and are largely dependent on sunlight to maintain adequate vitamin D status. A very high prevalence (50-100%) of severe vitamin D deficiency (serum 25 (OH) D levels o25 nmol/l) has been reported in older studies of elderly (generally 465 y) hospitalised and community-dwelling Irish subjects during wintertime (McKenna et al, 1981 (McKenna et al, , 1985 Meade et al, 1986; Freaney et al, 1993) . Moreover, Freaney et al (1993) found that 32% of a group of free-living ambulatory elderly Irish subjects had severe vitamin D deficiency during summertime. There is much current debate about the serum 25 (OH) D cutoff levels defining vitamin D adequacy/ sufficiency (Zittermann, 2003; Lips, 2004) , with some suggesting that levels as high as 80-100 nmol/l are required (Zittermann, 2003; Holick, 2004) , which would mean that much greater proportions of elderly Irish subjects may have suboptimal vitamin D status.
While several studies have indicated that elderly among various populations are at particular risk of suboptimal status (Lips, 2001) , less is known about vitamin D status in younger postmenopausal women, a subgroup of the population also at increased risk of osteopenia and osteoporosis. A range of recommended vitamin D intakes (0-10 mg/day) has been set for Irish adults aged up to 65 y, which allows for a variety of sun exposure during summer, while 10 mg/day is recommended for Irish adults aged 65 y and older (Food Safety Authority of Ireland, 1999) . About 88% of 51-to 64-y-old Irish adult women fail to reach intakes of 10 mg/day (Hill et al, 2004) . The significance of these low intakes for vitamin D status in this age group is unknown, especially during wintertime.
Therefore, the objective of the present study was to assess vitamin D status during late-summer and late-winter/earlyspring in postmenopausal Irish women (aged 51-69 y), and to estimate vitamin D intake in this group of women. In addition, the impact of using vitamin D-containing supplements on vitamin D status was also assessed.
Subjects and methods

Subjects
A convenience sample of 63 apparently healthy, free-living adult women (mean age 59.8 (range 51.0-68.7 y)) were recruited by leaflet or direct contact from the Cork region. None of the subjects were suffering from any condition likely to affect vitamin D status. Women were excluded if they were taking medicines likely to affect vitamin D status or calcium metabolism (such as active vitamin D metabolites, parathyroid hormone (PTH), anticonvulsants, steroid hormones). Four of the women were taking very high levels of supplemental vitamin D (56-63 mg/day), which is nonreflective of levels in vitamin D-containing supplements used by women aged 50 y and older in the general Irish population (Kiely et al, 2001) , as well as being higher than the tolerable upper intake level (50 mg/day; Institute of Medicine, 1997) . Therefore, these women were excluded from further analysis. The mean (s. 
Ethical considerations
Before participation in this study, all subjects signed an informed consent document approved by the Clinical Research Ethics Committee of the Cork Teaching Hospitals.
Design
This study was a longitudinal observational study of seasonal differences in vitamin D status in 51-to 69-y-old women. Each participant was invited to provide a fasting blood sample at the University on three separate occasions: February/March 2002, August/September 2002 and again in February/March 2003. After an overnight fast, a blood sample (20 ml) was taken between 0830 and 1030 hours on each of the three occasions. Anthropometric measurements (weight and height) were taken. Habitual food intake was assessed by a 14-day diet history, which consisted of a oneto-one interview detailing usual food and drink intakes in a typical 14-day period. Food intakes were quantified using a photographic food atlas of food portion sizes (Ministry of Agriculture, Fisheries and Food, 1997). The dietary history was administered to one-third of participants at each of the three visits so that the full sample had been assessed by the end of the third visit. We have previously shown that dietary vitamin D intake within Irish adults does not differ between summer-and wintertime (Hill et al, 2004) . A general health and lifestyle questionnaire was administered to each participant during each visit, which provided information on medical history, use of hormone replacement therapy, visits Collection and preparation of samples Blood was collected by venepuncture into a vacutainer tube with no additive and processed to serum, which was immediately stored at À801C until required for analysis.
Experimental techniques
Serum intact parathyroid hormone. Serum intact parathyroid hormone (iPTH) levels were measured in serum using an ELISA (OCTEIA s Intact parathyroid hormone, Immuno Diagnostic Systems Ltd, Boldon, UK). The intra-and interassay CV was 3.4 and 3.8%, respectively. Based on the manufacturer's information, the suggested normal range for PTH is 0.8-3.9 pmol/l, while values between 4.1 and 29.0 pmol/l are suggestive of primary hyperparathyroidism.
Serum 25-hydroxyvitamin D. Serum 25-hydroxyvitamin D (25 (OH) D) levels were measured in serum samples using a recently developed ELISA (OCTEIA s 25-Hydroxy Vitamin D, Immuno Diagnostic Systems Ltd, Boldon, UK). The intraand interassay CV was 5.9 and 6.6%, respectively. The quality and accuracy of the serum 25 (OH) D analysis in this laboratory was assured on an ongoing basis by participation in the Vitamin D External Quality Assessment Scheme (DEQAS, Charing Cross Hospital, London, UK). There is no international consensus on cutoff levels for vitamin D deficiency and vitamin D insufficiency (McKenna & Freaney, 1998) . Therefore, for illustrative and comparative purposes in the present study, three suggested sets of serum 25 (OH) D cutoff values for defining vitamin D status were used. These include the definitions of vitamin D status suggested by Heaney and Weaver (2003) 
480 nmol/l, sufficient), Vieth (1999) (440 nmol/l, adequate; 25-40 nmol/l, marginally deficient; o25 nmol/l; severely deficient) and Lips (2001) (450 nmol/l, replete; 25-50 nmol/l, mildly deficient; 12.5-25 nmol/l, moderately deficient; o12.5 nmol/l, severely deficient).
Serum calcium levels. Calcium was analysed in duplicate in serum samples by atomic absorption spectrophotometry (Spectr AA-600, Varian Australia Ltd, Victoria, Australia) after appropriate dilution with LaCl 3 solution (5 g/l; BDH Ltd, Poole, Dorset, UK). A range of calcium standards was used to obtain a calcium calibration curve. The intra-and interassay CV for calcium was 2.8 and 7.8%, respectively. The accuracy of mineral analysis was assured in each analytical run by appropriate recovery of mineral in a reference serum sample (Seronorm Trace Elementst: Serum, Nycomed, Olso, Norway).
Statistical analysis
Data are presented as means and standard deviations. Data for all variables (except vitamin D intakes) were normally distributed and allowed for parametric tests of significance. Seasonal differences in serum 25 (OH) D and PTH concentrations were analysed using repeated measures analysis of variance (ANOVA) (n ¼ 44 present at all three sampling points). Where significant (Po0.05) differences were found, Fisher's least significant difference test was used to perform post hoc comparison of all pairs of means (Snedecor & Cochran, 1967) . Differences in serum 25 (OH) D and PTH levels between vitamin D supplement users and nonusers, within a season, were evaluated using unpaired Student's t-tests. The difference in vitamin D intake from food sources only compared to all sources (food and supplements) was evaluated using a Wilcoxon's test. The difference in calcium intake from food sources only compared to all sources (food and supplements) was evaluated using a paired Student's t-test. A linear regression model was used to investigate the association between serum 25 (OH) D and PTH (levels averaged over the three sampling points; n ¼ 44). 
Results
Dietary intake of vitamin D and calcium
Impact of vitamin D supplement use on serum vitamin D and PTH levels
About 46, 25 and 40% of women took a vitamin Dcontaining supplement during the three respective sampling points. The vitamin D content of the supplements ranged from 2.5 to 20 mg, and the mean content of vitamin D was similar (6.2, 7.7 and 7.0 mg; P ¼ 0.290) for the three respective sampling points. Stratification of women into vitamin Dcontaining supplement 'users' and 'nonusers' revealed that mean serum 25 (OH) D levels were significantly higher (Pr0.05) in users than nonusers at all three sampling points (Figure 1 ). There was no effect of vitamin D-containing Mean values within a row with unlike superscript letters were significantly different (ANOVA followed by Fisher's least significance test; Po0.001).
Based on the manufacturer's information, the suggested normal range for PTH is 0.8-3.9 pmol/l, while values between 4.1 and 29.0 pmol/l are suggestive of primary hyperparathyroidism. 
Prevalence of vitamin D deficiency
The percentages of women classified as vitamin D adequate/ sufficient or deficient/insufficient according to a number of suggested serum 25 (OH) D cutoff levels are shown in (Table 2) .
Relationship between serum 25 (OH) D and serum PTH
Using a linear regression model, there was a significant inverse correlation between serum 25 (OH) D levels and serum PTH levels (r ¼ À0.33;. P ¼ 0.028).
Discussion
In the present study, the mean daily vitamin D intake of Irish postmenopausal women (51-69 y old) was 5.8 mg from all sources (ie, food and nutritional supplements) and 3.2 mg from food sources only. These intake estimates are in line with those recently reported for a nationally representative sample of Irish adult women (50-to 64-y-old) (5.1 mg from food and supplements and 3.4 mg from food sources only) (Hill et al, 2004) . The problem with establishing appropriate Dietary Reference Values (DRVs) for vitamin D has been a long-standing one. Determining the amount of vitamin D provided by sunlight is difficult. For this reason, an RDA of 0-10 mg/day has been set for adults aged up to 65 y and 10 mg/day for adults 65 y and older (Food Safety Authority of Ireland, 1999). In the US, it is recommended that 51-y-olds and older consume at least 10 mg vitamin D daily (Institute of Medicine, 1997) to help counteract the slower rate of skin production with age, and thus to maintain adequate serum levels of 25 (OH) D for bone health. Similarly, the Food and Agriculture Organization/World Health Organization expert group on human vitamin and mineral requirements recommends 10 mg/day for adults 50 y and older (Food and Agriculture Organization/World Health Organization, 1998). The mean daily intake of vitamin D in the current sample of 51-to 69-y-old Irish women (5.8 mg/day) is below this recommendation, and furthermore, 84% of the group of women failed to reach the recommendation of 10 mg/day. These low values are consistent with vitamin D intake data from other European countries (McKenna, 1992; Van Der Wielen et al, 1995; Rasmussen et al, 2000 ; see reviews by Lips, 2001; Henderson et al, 2003; Ovesen et al, 2003) .
Of particular interest in the current study was the much lower prevalence of vitamin D inadequacy/insufficiency in supplement users compared with nonusers, especially during late-winter/early-spring (a time at which vitamin D status is at its lowest). These findings suggest that the use of vitamin D-containing supplements was to some degree protective of vitamin D status. However, the level of protection offered by vitamin D-containing supplements depends on the serum 25 (OH) D cutoff values of vitamin D adequacy/sufficiency applied. For example, in the present study, the vitamin D content of the supplements used by the women ranged from 2.5 to 20 mg, with a mean content of 7.5 mg. At this supplemental level, 81-100 and 56-95% of women had adequate vitamin D status (defined as serum 25 (OH) D440 nmol/l (Vieth, 1999) and 450 nmol/l (Lips, 2001) , respectively) during wintertime. However, if a serum 25 (OH) D cutoff level of 480 nmol/l (Heaney & Weaver, 2003) is applied, then a much lower proportion of the postmenopausal women had sufficient vitamin D status during wintertime, suggesting that higher supplemental levels of vitamin D may be required. It is noteworthy that DawsonHughes et al (1997a) reported that at least 20 mg/day is required to prevent osteoporosis. In the present study, only 2% of the women had an intake of 20 mg/day, and none of the woman were able to achieve a dietary intake Z20 mg/day without using supplements. In the elderly women, there was a seasonal variation in serum 25 (OH) D levels among both supplement users and nonusers, suggesting that supplement use during summertime still, on average, conferred a benefit to vitamin D status. The seasonal variation in serum 25 (OH) D levels observed in postmenopausal women in the present study has been reported in other studies of more elderly Irish subjects (McKenna et al, 1985; Freaney et al, 1993) , as well as in various other European populations (see reviews by Lips, 2001; Ovesen et al, 2003; Zittermann, 2003) . The high levels of serum 25 (OH) D during second winter sampling point compared to the first may have related to the higher number of total hours of daily sunshine in the former compared to the latter, as well as the greater number of women taking a sun-holiday in the 3 month prior to blood sampling. It is also possible that by the third visit women may have been more aware of possible vitamin D deficiency during winter and took steps to improve their status, such as taking a sun-holiday or consciously obtaining more sunlight exposure.
The secretion of PTH has also been suggested as a biochemical marker for vitamin D deficiency McKenna & Freaney, 1998) . In the present study, a significant inverse correlation between serum 25 (OH) D and serum PTH was observed in the postmenopausal women, which is in line with the findings of some Dawson-Hughes et al, 1997b) but not other studies (Chapuy et al, 1987; Rapuri et al, 2002) . Serum PTH concentration also exhibited a seasonal variation (from February/March 2002 to August/September 2002) in postmenopausal women in the present study. Serum PTH levels were significantly higher during February/March 2003 than February/March 2002, even though serum 25 (OH) D levels were significantly higher during the former. However, when four women with secondary hyperparathyroidism during February/March 2003 were excluded, there was no significant difference in serum PTH levels between the two winter sampling periods. The underlying reason for the secondary hyperparathyroidism in these women is unclear; their serum 25 (OH) D levels were low to normal. However, in addition to being influenced by serum 25 (OH) D levels, serum PTH is also affected by dietary calcium (Karkkainen et al, 1997) and phosphate (Miyamoto et al, 2000) intake and kidney function (Freaney et al, 1993) among other factors.
Conclusion
The findings of the present study show that inadequate vitamin D status (serum 25 (OH) D levels below 40 or 50 nmol/l) is quite common in postmenopausal Irish women aged 51-69 y. These findings extend existing data, which show a high prevalence of vitamin D deficiency in elderly (generally 465 y) Irish subjects (McKenna et al, 1981 (McKenna et al, , 1985 Meade et al, 1986; Freaney et al, 1993) . While bone status measurements were not assessed in the present study, there is considerable evidence to suggest that vitamin D deficiency and inadequacy (defined as serum 25 (OH) D levels below 25 and 40 nmol/l, respectively) may be detrimental to bone health in adults (for reviews, see Institute of Medicine, 1997; Food and Agriculture Organization/World Health Organization, 1998; Lips, 2001) . Therefore, the impact of this inadequate vitamin D status on bone health in postmenopausal women needs to be investigated. Vitamin D supplementation was associated with a considerably lower prevalence of inadequacy/insufficiency of vitamin D in postmenopausal Irish women in the present study. Vitamin D supplementation was also associated with improved vitamin D status in the postmenopausal women during summertime, suggesting that summer sunlight exposure was not sufficient to optimise vitamin D status.
